Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Chitosan-based intelligent theragnosis nanocomposites enable pH-sensitive drug release with MR-guided imaging for cancer therapy.

Lim EK, Sajomsang W, Choi Y, Jang E, Lee H, Kang B, Kim E, Haam S, Suh JS, Chung SJ, Huh YM.

Nanoscale Res Lett. 2013 Nov 8;8(1):467. doi: 10.1186/1556-276X-8-467.

2.

Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.

Qin Y, Chen J, Bi Y, Xu X, Zhou H, Gao J, Hu Y, Zhao Y, Chai Z.

Acta Biomater. 2015 Apr;17:201-9. doi: 10.1016/j.actbio.2015.01.026. Epub 2015 Jan 30.

PMID:
25644449
3.

Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.

Unsoy G, Khodadust R, Yalcin S, Mutlu P, Gunduz U.

Eur J Pharm Sci. 2014 Oct 1;62:243-50. doi: 10.1016/j.ejps.2014.05.021. Epub 2014 Jun 12.

PMID:
24931189
4.

PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.

Scheeren LE, Nogueira DR, Macedo LB, Vinardell MP, Mitjans M, Infante MR, Rolim CM.

Colloids Surf B Biointerfaces. 2016 Feb 1;138:117-27. doi: 10.1016/j.colsurfb.2015.11.049. Epub 2015 Nov 28.

PMID:
26674840
5.

Synthesis and characterisation of a pH-sensitive magnetic nanocomposite for controlled delivery of doxorubicin.

Xu SS, Wu J, Jiang W.

J Microencapsul. 2015;32(6):533-7. doi: 10.3109/02652048.2015.1065918. Epub 2015 Aug 18.

PMID:
26289219
6.

Synthesis of doxorubicin-PLGA loaded chitosan stabilized (Mn, Zn)Fe2O4 nanoparticles: Biological activity and pH-responsive drug release.

Montha W, Maneeprakorn W, Buatong N, Tang IM, Pon-On W.

Mater Sci Eng C Mater Biol Appl. 2016 Feb;59:235-40. doi: 10.1016/j.msec.2015.09.098. Epub 2015 Sep 30.

PMID:
26652369
7.

Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging.

Zhu L, Wang D, Wei X, Zhu X, Li J, Tu C, Su Y, Wu J, Zhu B, Yan D.

J Control Release. 2013 Aug 10;169(3):228-38. doi: 10.1016/j.jconrel.2013.02.015. Epub 2013 Feb 26.

PMID:
23485450
8.

Facile solvothermal synthesis of mesostructured Fe3O4/chitosan nanoparticles as delivery vehicles for pH-responsive drug delivery and magnetic resonance imaging contrast agents.

Zhao G, Wang J, Peng X, Li Y, Yuan X, Ma Y.

Chem Asian J. 2014 Feb;9(2):546-53. doi: 10.1002/asia.201301072. Epub 2013 Nov 20.

PMID:
24259489
9.

Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.

Feng W, Nie W, He C, Zhou X, Chen L, Qiu K, Wang W, Yin Z.

ACS Appl Mater Interfaces. 2014 Jun 11;6(11):8447-60. doi: 10.1021/am501337s. Epub 2014 Apr 30.

PMID:
24745551
10.

Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.

Feng Q, Zhang Y, Zhang W, Hao Y, Wang Y, Zhang H, Hou L, Zhang Z.

Acta Biomater. 2017 Feb;49:402-413. doi: 10.1016/j.actbio.2016.11.035. Epub 2016 Nov 24.

PMID:
27890732
11.

Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.

Feng C, Wang Z, Jiang C, Kong M, Zhou X, Li Y, Cheng X, Chen X.

Int J Pharm. 2013 Nov 30;457(1):158-67. doi: 10.1016/j.ijpharm.2013.07.079. Epub 2013 Sep 9.

PMID:
24029170
12.

Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.

Nogueira-Librelotto DR, Scheeren LE, Vinardell MP, Mitjans M, Rolim CM.

Colloids Surf B Biointerfaces. 2016 Nov 1;147:326-35. doi: 10.1016/j.colsurfb.2016.08.014. Epub 2016 Aug 12.

PMID:
27543694
13.

Iron(III)-Based Magnetic Resonance-Imageable Liposomal T1 Contrast Agent for Monitoring Temperature-Induced Image-Guided Drug Delivery.

Kneepkens E, Fernandes A, Nicolay K, GrĂ¼ll H.

Invest Radiol. 2016 Nov;51(11):735-745.

PMID:
27309776
14.

Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging.

Chiang WH, Huang WC, Chang CW, Shen MY, Shih ZF, Huang YF, Lin SC, Chiu HC.

J Control Release. 2013 Jun 28;168(3):280-8. doi: 10.1016/j.jconrel.2013.03.029. Epub 2013 Apr 4.

PMID:
23562635
15.

Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells.

Talaei F, Azizi E, Dinarvand R, Atyabi F.

Int J Nanomedicine. 2011;6:1963-75. doi: 10.2147/IJN.S22731. Epub 2011 Sep 14.

16.

Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.

Wu J, Tang C, Yin C.

Acta Biomater. 2017 Jan 1;47:81-90. doi: 10.1016/j.actbio.2016.10.012. Epub 2016 Oct 10.

PMID:
27729232
17.

In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.

Guo H, Zhang D, Li T, Li C, Guo Y, Liu G, Hao L, Shen J, Qi L, Liu X, Luan J, Zhang Q.

J Pharm Sci. 2014 Mar;103(3):987-93. doi: 10.1002/jps.23875. Epub 2014 Jan 24.

PMID:
24549734
18.

Magnetically targeted delivery of DOX loaded Cu9S5@mSiO2@Fe3O4-PEG nanocomposites for combined MR imaging and chemo/photothermal synergistic therapy.

Liu B, Zhang X, Li C, He F, Chen Y, Huang S, Jin D, Yang P, Cheng Z, Lin J.

Nanoscale. 2016 Jul 7;8(25):12560-9. doi: 10.1039/c5nr06322a. Epub 2015 Nov 16.

PMID:
26568135
19.

Covalent attachment of Mn-porphyrin onto doxorubicin-loaded poly(lactic acid) nanoparticles for potential magnetic resonance imaging and pH-sensitive drug delivery.

Jing L, Liang X, Li X, Yang Y, Dai Z.

Acta Biomater. 2013 Dec;9(12):9434-41. doi: 10.1016/j.actbio.2013.08.018. Epub 2013 Aug 17.

PMID:
23962645
20.

A robust pH-sensitive drug carrier: aqueous micelles mineralized by calcium phosphate based on chitosan.

Lv Y, Huang H, Yang B, Liu H, Li Y, Wang J.

Carbohydr Polym. 2014 Oct 13;111:101-7. doi: 10.1016/j.carbpol.2014.04.082. Epub 2014 Apr 28.

PMID:
25037334

Supplemental Content

Support Center